Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is finding
success through its ability to form subsidiaries specializing in the use of its
patented drug-delivery platform, DehydraTECH. A recent article discussing the
company reads, “DehydraTECH is a drug-delivery platform patented for
cannabidiol and all other nonpsychoactive cannabinoids, as well as THC
(tetrahydrocannabinol) and psychoactive cannabinoids. The technology is an
enabling platform that works across multiple industries, thereby providing a
large base of consumers with healthier forms of consumption than lighting up. .
. . LXRP and DehydraTECH stand out among the competition. The company has a
total of 10 patents issued with more than 50 patents pending worldwide. Few
companies within the cannabis industry have attracted the attention of Fortune
500-type corporations, and even fewer are inking deals on their own terms.
Lexaria Bioscience is one such standout.”
To view the full article, visit http://ibn.fm/lKoCl
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and quicker onset of lipophilic active molecules. Lexaria has 10
patents granted in the United States and Australia, and has filed over 50
patent applications worldwide across 10 patent families. Lexaria’s technology
provides more rapid delivery to the bloodstream, as well as important
taste-masking benefits for orally administered bioactive molecules including
cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine
and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment